Cargando…

Progression of Androgen‐sensitive Mouse Tumor (Shionogi Carcinoma 115) to Androgen‐insensitive Tumor after Long‐term Removal of Testosterone

Shionogi Carcinoma 115 (SC115) is an androgen‐sensitive transplantable mouse tumor. To study the mode of progression from androgen‐sensitive to ‐insensitive tumor, cloned SC115 cells were serially cultured without androgen. Shortly after withdrawal of androgen, SC115 cells showed markedly decreased...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Naohide, Watabe, Yoshio, Suzuki, Hiroyoshi, Shimazaki, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1993
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919107/
https://www.ncbi.nlm.nih.gov/pubmed/8294220
http://dx.doi.org/10.1111/j.1349-7006.1993.tb02838.x
_version_ 1783317564528525312
author Sato, Naohide
Watabe, Yoshio
Suzuki, Hiroyoshi
Shimazaki, Jun
author_facet Sato, Naohide
Watabe, Yoshio
Suzuki, Hiroyoshi
Shimazaki, Jun
author_sort Sato, Naohide
collection PubMed
description Shionogi Carcinoma 115 (SC115) is an androgen‐sensitive transplantable mouse tumor. To study the mode of progression from androgen‐sensitive to ‐insensitive tumor, cloned SC115 cells were serially cultured without androgen. Shortly after withdrawal of androgen, SC115 cells showed markedly decreased growth, but growth resumed gradually with loss of response to androgen and the cells 60 weeks after androgen removal [A(—)60 cells] grew faster than SC115 cells cultured in the presence of androgen. A(—)60 cells showed malignant phenotype with morphological changes and tumorigenicity in male and female mice. Although mRNA and binding capacity of androgen receptor were maintained, the cells after removal of androgen rapidly lost expression of mouse mammary tumor virus‐related gene and the loss was irreversible in A(—)60 cells. The stimulating effect of basic flbroblast growth factor (bFGF) temporarily decreased, then recovered to the initial level after long‐term androgen removal. This fluctuation of response to bFGF was accompanied with changes in the number of bFGF receptors and amount of bFGF‐like substance(s) secreted. The substance(s) seemed to be an FGF‐like growth factor different from known factors. It was concluded that progression of SC115 cells to androgen‐insensitive ones under an androgen‐deprived condition proceeded with adaptation by means of increases in production of an FGF‐like growth factor and in binding capacity to this factor.
format Online
Article
Text
id pubmed-5919107
institution National Center for Biotechnology Information
language English
publishDate 1993
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-59191072018-05-11 Progression of Androgen‐sensitive Mouse Tumor (Shionogi Carcinoma 115) to Androgen‐insensitive Tumor after Long‐term Removal of Testosterone Sato, Naohide Watabe, Yoshio Suzuki, Hiroyoshi Shimazaki, Jun Jpn J Cancer Res Article Shionogi Carcinoma 115 (SC115) is an androgen‐sensitive transplantable mouse tumor. To study the mode of progression from androgen‐sensitive to ‐insensitive tumor, cloned SC115 cells were serially cultured without androgen. Shortly after withdrawal of androgen, SC115 cells showed markedly decreased growth, but growth resumed gradually with loss of response to androgen and the cells 60 weeks after androgen removal [A(—)60 cells] grew faster than SC115 cells cultured in the presence of androgen. A(—)60 cells showed malignant phenotype with morphological changes and tumorigenicity in male and female mice. Although mRNA and binding capacity of androgen receptor were maintained, the cells after removal of androgen rapidly lost expression of mouse mammary tumor virus‐related gene and the loss was irreversible in A(—)60 cells. The stimulating effect of basic flbroblast growth factor (bFGF) temporarily decreased, then recovered to the initial level after long‐term androgen removal. This fluctuation of response to bFGF was accompanied with changes in the number of bFGF receptors and amount of bFGF‐like substance(s) secreted. The substance(s) seemed to be an FGF‐like growth factor different from known factors. It was concluded that progression of SC115 cells to androgen‐insensitive ones under an androgen‐deprived condition proceeded with adaptation by means of increases in production of an FGF‐like growth factor and in binding capacity to this factor. Blackwell Publishing Ltd 1993-12 /pmc/articles/PMC5919107/ /pubmed/8294220 http://dx.doi.org/10.1111/j.1349-7006.1993.tb02838.x Text en
spellingShingle Article
Sato, Naohide
Watabe, Yoshio
Suzuki, Hiroyoshi
Shimazaki, Jun
Progression of Androgen‐sensitive Mouse Tumor (Shionogi Carcinoma 115) to Androgen‐insensitive Tumor after Long‐term Removal of Testosterone
title Progression of Androgen‐sensitive Mouse Tumor (Shionogi Carcinoma 115) to Androgen‐insensitive Tumor after Long‐term Removal of Testosterone
title_full Progression of Androgen‐sensitive Mouse Tumor (Shionogi Carcinoma 115) to Androgen‐insensitive Tumor after Long‐term Removal of Testosterone
title_fullStr Progression of Androgen‐sensitive Mouse Tumor (Shionogi Carcinoma 115) to Androgen‐insensitive Tumor after Long‐term Removal of Testosterone
title_full_unstemmed Progression of Androgen‐sensitive Mouse Tumor (Shionogi Carcinoma 115) to Androgen‐insensitive Tumor after Long‐term Removal of Testosterone
title_short Progression of Androgen‐sensitive Mouse Tumor (Shionogi Carcinoma 115) to Androgen‐insensitive Tumor after Long‐term Removal of Testosterone
title_sort progression of androgen‐sensitive mouse tumor (shionogi carcinoma 115) to androgen‐insensitive tumor after long‐term removal of testosterone
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919107/
https://www.ncbi.nlm.nih.gov/pubmed/8294220
http://dx.doi.org/10.1111/j.1349-7006.1993.tb02838.x
work_keys_str_mv AT satonaohide progressionofandrogensensitivemousetumorshionogicarcinoma115toandrogeninsensitivetumorafterlongtermremovaloftestosterone
AT watabeyoshio progressionofandrogensensitivemousetumorshionogicarcinoma115toandrogeninsensitivetumorafterlongtermremovaloftestosterone
AT suzukihiroyoshi progressionofandrogensensitivemousetumorshionogicarcinoma115toandrogeninsensitivetumorafterlongtermremovaloftestosterone
AT shimazakijun progressionofandrogensensitivemousetumorshionogicarcinoma115toandrogeninsensitivetumorafterlongtermremovaloftestosterone